The aim of this study was to evaluate the expression of the key regulatory genes - RIPK1, RIPK3, and MLKL - in surgically resected NSCLC and to investigate their association with clinical features and surgical outcome. This evidence concerns the gene RIPK3 and non-small cell lung carcinoma.